Home › Cardiovasculaire ziekte › Tennessee › Nashville
Cardiovasculaire ziekte klinische studies in Nashville, TN
18 studies voor Cardiovasculaire ziekte zoeken deelnemers op locaties in en rond Nashville (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RekruterenFase 4
- TriStar Centennial Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Rekruteren
- Saint Thomas Research Institute, Nashville
Improving Veteran Referral to Cardiac Rehabilitation
Rekruteren
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Product Surveillance Registry
RekruterenObservatieonderzoek
- Nashville, Nashville
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Rekruteren
- Vanderbilt University Medical Center, Nashville
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekruterenFase 3
- Vanderbilt Univ Medi Cen, Nashville
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Rekruteren
- Vanderbilt University Medical Center, Nashville
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RekruterenFase 4Gezonde vrijwilligers welkom
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
RekruterenFase 2
- Vanderbilt University Medical Center, Nashville
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruterenFase 3
- Research Site, Nashville
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekruterenFase 3
- Ascension Saint Thomas, Nashville
Global Paradise System US Post Approval Study
RekruterenObservatieonderzoek
- Ascension Saint Thomas, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekruteren
- Vanderbilt, Nashville
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
RekruterenFase 2
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekruteren
- Centennial Medical Center, Nashville
Randomized Trial of SGLT2i in Heart Transplant Recipients
RekruterenFase 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Gut Microbiota in Metabolic Surgery
RekruterenObservatieonderzoek
- Vanderbilt_University MC, Nashville
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Rekruteren
- Centennial Medical Center, Nashville
Cardiovasculaire ziekte studies in andere steden
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Atlanta, GA22 studies
- Cleveland, OH22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Los Angeles, CA18 studies
Andere studies in Nashville
- Niet-kleincellige longkanker97 studies
- Borstkanker81 studies
- Metastatische kanker70 studies
- Colorectale kanker69 studies
- Kanker (alle vormen)65 studies
- Eierstokkanker49 studies
- Prostaatkanker43 studies
- Longkanker40 studies
- Plaveiselcelcarcinoom van hoofd en hals39 studies
- Aldermeesklierkanker39 studies
- Endometriumkanker38 studies
- Melanoom33 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.